[go: up one dir, main page]

WO2008133744A3 - Préparation d'échantillons pour l'essai de détection d'antigènes - Google Patents

Préparation d'échantillons pour l'essai de détection d'antigènes Download PDF

Info

Publication number
WO2008133744A3
WO2008133744A3 PCT/US2007/086894 US2007086894W WO2008133744A3 WO 2008133744 A3 WO2008133744 A3 WO 2008133744A3 US 2007086894 W US2007086894 W US 2007086894W WO 2008133744 A3 WO2008133744 A3 WO 2008133744A3
Authority
WO
WIPO (PCT)
Prior art keywords
sample preparation
antigen detection
detection testing
samples
pooled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/086894
Other languages
English (en)
Other versions
WO2008133744A2 (fr
Inventor
William E Hessman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central States Testing LLC
Original Assignee
Central States Testing LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central States Testing LLC filed Critical Central States Testing LLC
Publication of WO2008133744A2 publication Critical patent/WO2008133744A2/fr
Publication of WO2008133744A3 publication Critical patent/WO2008133744A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne des procédés permettant de réduire des erreurs de faux négatif dans des essais de capture d'antigènes d'échantillons regroupés ou uniques. Les procédés sont particulièrement utiles pour détecter des échantillons contenant des antigènes lorsqu'ils sont regroupés avec d'autres échantillons contenant un agent inhibiteur.
PCT/US2007/086894 2006-12-08 2007-12-08 Préparation d'échantillons pour l'essai de détection d'antigènes Ceased WO2008133744A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86931906P 2006-12-08 2006-12-08
US60/869,319 2006-12-08

Publications (2)

Publication Number Publication Date
WO2008133744A2 WO2008133744A2 (fr) 2008-11-06
WO2008133744A3 true WO2008133744A3 (fr) 2008-12-31

Family

ID=39926252

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/086894 Ceased WO2008133744A2 (fr) 2006-12-08 2007-12-08 Préparation d'échantillons pour l'essai de détection d'antigènes

Country Status (1)

Country Link
WO (1) WO2008133744A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415996A (en) * 1993-10-20 1995-05-16 Olsson; Lennart Prognostic markers in human breast cancer
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415996A (en) * 1993-10-20 1995-05-16 Olsson; Lennart Prognostic markers in human breast cancer
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples

Also Published As

Publication number Publication date
WO2008133744A2 (fr) 2008-11-06

Similar Documents

Publication Publication Date Title
MX2011010826A (es) Dispositivos para diagnostico y métodos relacionados.
BRPI0809138B8 (pt) método para detectar a presença ou quantidade de um ou mais analitos em uma amostra biológica
WO2008096225A3 (fr) Coffret et procédé de détection de médicament
WO2009088816A8 (fr) Systèmes et procédés d'analyse de données de puits
WO2006088904A3 (fr) Dispositif de test d'echantillon fecal et procedes d'utilisation de celui-ci
GB2449043A (en) Water soluble conjugates for electrochemical detection
EP2182365A3 (fr) Analyseur d'échantillon
WO2006098772A3 (fr) Systemes et procedes d'optimisation de mesures
WO2009029550A3 (fr) Système ultra-sensible et procédés d'analyse d'antigène spécifique de la prostate (psa)
NZ629703A (en) Methods and compositions for detecting multiple analytes with a single signal
WO2007116324A3 (fr) Dispositif conçu pour tester des aliments de consommation
MX2009009125A (es) Deteccion de falta de señal.
WO2006089027A3 (fr) Kit d'analyse a ecoulement lateral et procede de detection d'analyte
WO2010051544A3 (fr) Plateforme de diagnostic rapide homogène basée sur le transfert d'énergie par résonance de fluorescence des lanthanides
WO2008117067A3 (fr) Procédé, assemblage et utilisation de celui-ci
WO2008011158A3 (fr) Procédé de détection et/ou de mesure de la concentration d'hepcidine dans un échantillon
EP2273168A3 (fr) Détection des fautes des vannes
WO2009007846A3 (fr) Procédé pour modifier, isoler, détecter, visualiser et quantifier des peptides, polypeptides et protéines contenant de la citrulline et/ou de l'homocitrulline
WO2011062407A3 (fr) Procédé et dispositif pour détecter des substances à analyser
WO2009103843A3 (fr) Méthode et dispositif de détection d'un analyte
EP4524553A3 (fr) Analyse diagnostique de développement définitif
WO2009113044A3 (fr) Procédé de détection et de quantification extrêmement sensibles de biomolécules au moyen d’une spectrométrie de masse des ions secondaires (sims) et technologies liées
WO2007005666A3 (fr) Systeme et methode de detection d'analytes au moyen de recepteurs differentiels
WO2012032345A3 (fr) Signatures de biomarqueurs et leurs applications
TW200741203A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07874356

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07874356

Country of ref document: EP

Kind code of ref document: A2